|
Phase 3b, Open-label, Multicenter, Single-dose Study Investigating Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy Administered to Adult Subjects with Severe or Moderately Severe Hemophilia B with Detectable Pretreatment AAV5 Neutralizing Antibodies
|
Ongoing
|
HEMGENIX (etranacogene dezaparvovec)
|
3b
|
CSL222_3005
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
Long-term pain and adherence observational study for Endometriosis treatment
|
Ongoing
|
Duphaston
|
4
|
DYDR-522-0318
|
Dr.Arab Clinic
|
|
Real world Assessment of Dyslipidemia patients on Inclisiran effiCacy And toLerability: The RADICAL Study
|
Ongoing
|
LEQVIO
|
4
|
CKJX839A1S
|
Dallah Hospital (Riyadh)
|
|
Effect of celecoxib on postoperative narcotic use and disease severity in patients with aspirin-exacerbated respiratory disease and chronic rhinosinusitis: a randomized controlled trial
|
Ongoing
|
Celecoxib
|
4
|
114809
|
King Khalid University Hospital (Riyadh), King Abdulaziz University Hospital (Riyadh)
|
|
EASi-HF - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral BI 690517 and empagliflozin compared with placebo and empagliflozin in participants with symptomatic heart failure (HF: NYHA II-IV) and left ventricular ejection fraction (LVEF) >40%
|
Ongoing
|
BI 690517 , empagliflozin
|
3
|
1378-0020
|
King Fahad Medical City (Riyadh), King Khalid University Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
Effect of Probiotics “Psychobiotics” on Depression in Adults with Obesity and Metabolic Syndrome in Riyadh City
|
Ongoing
|
Winclove’s Ecologic® Barrier probiotics
|
3
|
E-23-7867
|
King Khalid University Hospital (Riyadh)
|
|
A Phase 3 Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
|
Rejected
|
Nipocalimab
|
3
|
80202135EBF3001
|
King Faisal Specialist Hospital and Research Center (Riyadh), King Saud Medical City (Riyadh), King Fahad University Hospital (Al-Khobar)
|
|
REAL-WORLD, LONG-TERM DATA COLLECTION TO GAIN CLINICAL INSIGHTS INTO ROCHE OPHTHALMOLOGY PRODUCTS (VOYAGER STUDY)- COMPLETE
|
Ongoing
|
Vabysmo
|
4
|
MR41927
|
King Abdulaziz Medical City NG (Jeddah)
|
|
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants with Immunoglobulin A Nephropathy (IgAN)
|
Ongoing
|
Litifilimab
|
3
|
230LE305
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
A Multicenter, Open-label, Single-arm, Phase 3 Long-Term Extension Study to Evaluate Continuous Safety and Efficacy of BIIB059 (Litifilimab) in Adult Participants with Active Subacute Cutaneous Lupus Erythematosus and/or Chronic Cutaneous Lupus Erythematosus with or without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy (AMETHYST LTE)
|
Ongoing
|
Litifilimab
|
3
|
230LE305
|
King Faisal Specialist Hospital and Research Center ,(Riyadh) King Khalid University Hospital (Riyadh)
|
